Cathie's Ark Logo
undefined Logo

ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily

TherapeuticsGene TherapyCAR-T Cell TherapyCRSPR Gene Editing
Morning Brew Icon
China's One Ocean Problem
Date
Direction
Shares
Fund Weight
Fund
May 30, 2024
BUY11.875k0.0103%ARKK
May 21, 2024
BUY60.174k0.0484%ARKK
May 10, 2024
BUY72.455k0.0593%ARKK
May 9, 2024
BUY49.812k0.0404%ARKK
February 13, 2024
BUY228.975k0.2057%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
5.28%$5.01b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
6🇨🇭Switzerland
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
6$62.32
🎫ARK Ownership Percent
6.73%

Other ETFs That Hold CRSP

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.7%
GNOMGlobal X Genomics & Biotechnology ETF3.52%
ARKKARK Innovation ETF3.37%
XBISPDR® S&P Biotech ETF1.01%
IBBiShares Biotechnology ETF0.35%
LABUS&P Biotech Bull 3X Shares ETF0.242%

Research Notes and Commentary for CRSP

No Research Notes Found for CRSP